Cargando…
How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
Synthetic glucocorticoids serve as co-medication against solid malignant tumors. However, glucocorticoid receptor activation may promote unsolicited cancer resistance to chemotherapy. The Kang team elucidated a glucocorticoid receptor-centred chemotherapy-resistance mechanism to cisplatin and charac...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367998/ https://www.ncbi.nlm.nih.gov/pubmed/34400619 http://dx.doi.org/10.1038/s41467-021-24847-6 |